ID

14212

Description

A Trial of Ribavirin in Patients With ACLF Due to Hepatitis E Virus; ODM derived from: https://clinicaltrials.gov/show/NCT01698723

Lien

https://clinicaltrials.gov/show/NCT01698723

Mots-clés

  1. 04/04/2016 04/04/2016 -
Téléchargé le

4 avril 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Acute on Chronic Hepatic Failure NCT01698723

Eligibility Acute on Chronic Hepatic Failure NCT01698723

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
all aclf due to hev
Description

Acute-On-Chronic Liver Failure

Type de données

boolean

Alias
UMLS CUI [1]
C3850141
consent to participate in trial and collection of blood
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant and nursing mothers
Description

Patient pregnant

Type de données

boolean

Alias
UMLS CUI [1]
C0549206
severe anemia
Description

Anemia, severe

Type de données

boolean

Alias
UMLS CUI [1]
C0238644
other etiologies of aclf (eg. alcohol, drugs, reactivation of hepatitis b and hepatitis c, variceal bleeding, surgical intervention and sepsis)
Description

other etiologies of aclf

Type de données

boolean

Alias
UMLS CUI [1]
C3850141
hepatocellular carcinoma (hcc)
Description

Liver carcinoma

Type de données

boolean

Alias
UMLS CUI [1]
C2239176
hepatorenal syndrome (hrs) at admission
Description

Hepatorenal Syndrome

Type de données

boolean

Alias
UMLS CUI [1]
C0019212
presence of life threatening cardiovascular, respiratory and neurological disease
Description

Life Threatening Adverse Event

Type de données

boolean

Alias
UMLS CUI [1]
C1517874
acquired immunodeficiency syndrome
Description

Acquired Immunodeficiency Syndrome

Type de données

boolean

Alias
UMLS CUI [1]
C0001175
patients with hemoglobinopathies (e.g., thalassemia major, sickle-cell anemia)
Description

Hemoglobinopathies

Type de données

boolean

Alias
UMLS CUI [1]
C0019045
refusal to provide consent to participate in the study
Description

participate in the study

Type de données

boolean

Alias
UMLS CUI [1]
C2348568

Similar models

Eligibility Acute on Chronic Hepatic Failure NCT01698723

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Acute-On-Chronic Liver Failure
Item
all aclf due to hev
boolean
C3850141 (UMLS CUI [1])
Informed Consent
Item
consent to participate in trial and collection of blood
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Patient pregnant
Item
pregnant and nursing mothers
boolean
C0549206 (UMLS CUI [1])
Anemia, severe
Item
severe anemia
boolean
C0238644 (UMLS CUI [1])
other etiologies of aclf
Item
other etiologies of aclf (eg. alcohol, drugs, reactivation of hepatitis b and hepatitis c, variceal bleeding, surgical intervention and sepsis)
boolean
C3850141 (UMLS CUI [1])
Liver carcinoma
Item
hepatocellular carcinoma (hcc)
boolean
C2239176 (UMLS CUI [1])
Hepatorenal Syndrome
Item
hepatorenal syndrome (hrs) at admission
boolean
C0019212 (UMLS CUI [1])
Life Threatening Adverse Event
Item
presence of life threatening cardiovascular, respiratory and neurological disease
boolean
C1517874 (UMLS CUI [1])
Acquired Immunodeficiency Syndrome
Item
acquired immunodeficiency syndrome
boolean
C0001175 (UMLS CUI [1])
Hemoglobinopathies
Item
patients with hemoglobinopathies (e.g., thalassemia major, sickle-cell anemia)
boolean
C0019045 (UMLS CUI [1])
participate in the study
Item
refusal to provide consent to participate in the study
boolean
C2348568 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial